Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Phoenix Spree Deutschland Limited is a Jersey-incorporated property investment company focused on German residential real estate, with a particular emphasis on Berlin’s rental housing market. The company manages a portfolio of residential assets and also makes selective investments in commercial property, giving it exposure to broader German property segments. Its core activity is acquiring, managing, and realising value from mid-market residential properties, while maintaining a long-term focus on improving accommodation quality for tenants. Phoenix Spree Deutschland Limited plays a specialist role in the market by providing investors with access to German housing assets through a listed investment structure. Founded in 2007 and headquartered in London, the company operates across Germany through a property-led business model centred on residential investment and portfolio management.
£1.65
+£0.03 (+1.66%)
EOD Jul 3, 2026
Revenue declined 9.9% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 68% versus the prior year, cash generation momentum has weakened. Net debt of €219M represents 67.2x FCF, leverage limits flexibility.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€5M
▼ -9.9% YoY
Net Income (TTM)
-€6M
▲ +83.9% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF (TTM)
€3M
▼ -68.1% YoY
Op. Cash Flow (TTM)
€3M
▼ -67.1% YoY
Net Debt
€219M
Cash & Equiv.
€34M
3Y CAGR: +22.2%
3Y CAGR: +24.3%
Continue Research
Phoenix Spree Deutschland (PSDL.XLON) trades above a two-stage DCF intrinsic value of about €-1.77 per share, so at €1.65 the stock looks overvalued (207.1% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Phoenix Spree Deutschland scores 44/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about €-1.77 per share for PSDL.XLON, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around €-1.33. At today's €1.65, that puts the stock about 207.1% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Phoenix Spree Deutschland scores 44 out of 100 on Intrinsiqq's quality score, a weighted blend of 5 metrics each scored 0 to 100, which makes it a mixed business on these measures. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. PSDL.XLON currently trades above its estimated intrinsic value and scores 44/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.